End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapy
Abstract Autosomal dominant polycystic kidney disease (ADPKD) is commonly caused by PKD1, and mosaic PKD1 variants result in milder phenotypes. We present the case of a 32 year-old male with chronic active Epstein–Barr virus who underwent bone marrow transplantation with chemoradiotherapy at age 9....
Saved in:
Main Authors: | Hiroaki Hanafusa, Hiroshi Yamaguchi, Naoya Morisada, Ming Juan YE, Riki Matsumoto, Hiroaki Nagase, Kandai Nozu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2024-03-01
|
Series: | Human Genome Variation |
Online Access: | https://doi.org/10.1038/s41439-024-00273-0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel NFKB1 variant in a Japanese pedigree with common variable immunodeficiency
by: Naoko Nakatani, et al.
Published: (2024-03-01) -
G-quadruplex stabilization provokes DNA breaks in human PKD1, revealing a second hit mechanism for ADPKD
by: Agata M. Parsons, et al.
Published: (2025-01-01) -
4q25 Microdeletion with Axenfeld-Rieger Syndrome and Developmental Delay
by: Yukino Kawanami, et al.
Published: (2023-01-01) -
Seizure prevalence in children aged up to 3 years: a longitudinal population-based cohort study in Japan
by: Kandai Nozu, et al.
Published: (2020-09-01) -
Melanin-like nanoparticles as a potential novel therapeutic approach in ADPKD
by: Laura Cassina, et al.
Published: (2024-11-01)